Details for New Drug Application (NDA): 018893
✉ Email this page to a colleague
NDA 018893 describes SODIUM ACETATE, which is a drug marketed by Fresenius Kabi Usa, Hospira, and Milla Pharms, and is included in three NDAs. It is available from three suppliers. Additional details are available on the SODIUM ACETATE profile page.
The generic ingredient in SODIUM ACETATE is sodium acetate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sodium acetate profile page.
The generic ingredient in SODIUM ACETATE is sodium acetate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sodium acetate profile page.
Summary for 018893
| Tradename: | SODIUM ACETATE |
| Applicant: | Hospira |
| Ingredient: | sodium acetate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 018893
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 018893
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SODIUM ACETATE | sodium acetate | INJECTABLE;INJECTION | 018893 | NDA | Hospira, Inc. | 0409-3299 | 0409-3299-25 | 25 VIAL in 1 CASE (0409-3299-25) / 100 mL in 1 VIAL (0409-3299-45) |
| SODIUM ACETATE | sodium acetate | INJECTABLE;INJECTION | 018893 | NDA | Hospira, Inc. | 0409-3299 | 0409-3299-26 | 25 VIAL in 1 TRAY (0409-3299-26) / 50 mL in 1 VIAL (0409-3299-46) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2MEQ/ML | ||||
| Approval Date: | May 4, 1983 | TE: | AP | RLD: | Yes | ||||
Complete Access Available with Subscription
